Bone biopsy and densitometry findings in a child with Camurati-Engelmann disease

Clinical Rheumatology

Volumn 26, Issue 10, 2007, Pages 1773-1777

  Bondestam, Jonas ^a   Mäyränpää, Mervi K ^a   Ikegawa, Shiro ^b   Marttinen, Eino ^c   Kröger, Heikki ^d   Mäkitie, Outi ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b RIKEN   (Japan)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Bisphosphonate; Camurati Engelmann disease; Osteoporosis

Indexed keywords

GENOMIC DNA; PAMIDRONIC ACID; PREDNISOLONE; TETRACYCLINE; TRANSFORMING GROWTH FACTOR BETA1; BISPHOSPHONIC ACID DERIVATIVE;

AMINO ACID SUBSTITUTION; ANKLE FRACTURE; ARTICLE; BONE BIOPSY; BONE DENSITOMETRY; BONE DENSITY; BONE EROSION; BONE RADIOGRAPHY; CAMURATI ENGELMANN DISEASE; CASE REPORT; CHILD; DEVELOPMENTAL DISORDER; DRUG DOSE REDUCTION; DUAL ENERGY X RAY ABSORPTIOMETRY; DYSTONIA; FEMUR NECK; FIBULA FRACTURE; FRACTURE TREATMENT; GAIT DISORDER; GENE IDENTIFICATION; GENETIC SCREENING; HUMAN; HYPEROSTOSIS; ILIAC BONE; KNEE DISEASE; KNEE HYPEREXTENSION; MALE; MOTOR DEVELOPMENT; OSTEOBLAST; OSTEOCLAST; OSTEOPENIA; OSTEOPOROSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCOLIOSIS; STEROID THERAPY; WADDLING GAIT; WEIGHT GAIN; BIOPSY; BONE; CHEMISTRY; DENSITOMETRY; EXON; METABOLISM; METHODOLOGY; MUTATION; PATHOLOGY; TREATMENT OUTCOME; WHOLE BODY IMAGING;

BIOPSY; BONE AND BONES; CAMURATI-ENGELMANN SYNDROME; CHILD; DENSITOMETRY; DIPHOSPHONATES; EXONS; HUMANS; MALE; MUTATION; OSTEOPOROSIS; TRANSFORMING GROWTH FACTOR BETA1; TREATMENT OUTCOME; WHOLE BODY IMAGING;

EID: 38449102908     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-006-0511-z     Document Type: Article

References (19)

1. M Camurati 1922 Di uno raro caso di osteite simmetrica ereditaria degli arti inferiori Chir Organi Mov 6 662 665
2. G Engelmann 1929 Ein Fall von Osteopathia hyperostotica (sclerotisans) multiplex infantilis Fortschr Geb Rontgenstr Nuklearmed 39 1101 1106
3. A Kinoshita T Saito H Tomita, et al. 2000 Domain-specific mutations in TGFβ1 result in Camurati-Engelmann disease Nat Genet 26 19 20 10973241 10.1038/79128 1:CAS:528:DC%2BD3cXmsVKkurs%3D (Pubitemid 30692850)
4. K Janssens R Gershoni-Baruch N Guañabens, et al. 2000 Mutations in the gene encoding the latency-associated peptide of TGF-beta 1 cause Camurati-Engelmann disease Nat Genet 26 273 275 11062463 10.1038/81563 1:CAS:528:DC%2BD3cXotVWhsL0%3D (Pubitemid 30824604)
5. K Janssens F Vanhoenacker M Bonduelle, et al. 2006 Camurati-Engelmann Disease: review of the clinical, radiological and molecular data of 24 families and implications towards diagnostics and treatment J Med Genet 43 1 11 15894597 10.1136/jmg.2005.033522 1:CAS:528:DC%2BD28XhtF2hsr0%3D (Pubitemid 43099989)
6. G Cherie-Ligniere G Santalena A Parafioriti 1999 Pamidronate in the treatment of progressive diaphyseal dysplasia (Camurati-Engelmann disease) Clin Exp Rheumatol 17 264 10342062 1:STN:280:DyaK1M3ntlKjug%3D%3D (Pubitemid 29195841)
7. ZS Rubin G Ghiringhelli JL Mansur 1997 Clinical, humoral and scintigraphic assessment of a bisphosphonate as potential treatment of diaphyseal dysplasia: ribbing and Camurati-Engelmann diseases Medicina (B Aires) 57 56 60
8. T Inaoka N Shuke J Sato, et al. 2001 Scintigraphic evaluation of pamidronate and corticosteroid therapy in a patient with progressive diaphyseal dysplasia (Camurati-Engelmann disease) Clin Nucl Med 26 680 682 11452173 10.1097/00003072-200108000-00003 1:STN:280:DC%2BD3MvgtVCrtg%3D%3D (Pubitemid 32664265)
9. GR Castro S Appenzeller JF Marques-Neto, et al. 2005 Camurati-Engelmann disease: failure of response to bisphosphonates: report of two cases Clin Rheumatol 24 398 401 15660289 10.1007/s10067-004-1056-7 (Pubitemid 41102440)
10. A Kinoshita Y Fukumaki S Shirahama, et al. 2004 TGFB1 mutations in four new families with Camurati-Engelmann disease: confirmation of independently arising LAP-domain-specific mutations Am J Med Genet A 15 104 107 10.1002/ajmg.a.20671
11. RR Recker DB Kimmel AM Parfitt, et al. 1988 Static and tetracycline-based bone histomorphometric data from 34 normal menopausal females J Bone Miner Res 3 133 144 3213608 1:STN:280:BiaC3c3mvVI%3D
12. AM Parfitt MK Drezner FH Glorieux, et al. 1987 Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee J Bone Miner Res 2 595 610 3455637 1:STN:280:BieA3sfjsFc%3D
13. FH Glorieux R Travers A Taylor, et al. 2000 Normative data for iliac bone histomorphometry in growing children Bone 26 203 209 10.1016/S8756-3282(99) 00257-4 (Pubitemid 30029201)
14. K Janssens P ten Dijke S Janssens, et al. 2005 Transforming growth factor-beta1 to the bone Endocr Rev 26 740 743 10.1210/er.2004-0001 (Pubitemid 41428537)
15. NW McGowan H MacPherson K Janssens, et al. 2003 A mutation affecting the latency-associated peptide of TGFbeta1 in Camurati-Engelmann disease enhances osteoclast formation in vitro J Clin Endocrinol Metab 88 3321 3326 12843182 10.1210/jc.2002-020564 1:CAS:528:DC%2BD3sXlslaitbs%3D (Pubitemid 36877511)
16. E Canalis 2000 Glucocorticoid-induced osteoporosis Curr Opin Endocrinol Diabetes 7 320 324 10.1097/00060793-200012000-00005 1:CAS:528: DC%2BD3cXovFGntb0%3D
17. J Massagué J Cheifetz T Endo B Nadal-Ginard 1986 Type beta transforming growth factor is an inhibitor of myogenic differentiation Proc Natl Acad Sci USA 83 8206 8210 3022285 10.1073/pnas.83.21.8206 (Pubitemid 17182470)
18. RA Ignotz J Massagué 1985 Type beta transforming growth Factor controls the adipogenic differentiation of 3T3 fibroblasts Proc Natl Acad Sci USA 82 8530 8534 3001708 10.1073/pnas.82.24.8530 1:CAS:528:DyaL28Xmt1yksw%3D%3D
19. EB Sochett O Mäkitie 2005 Osteoporosis in chronically ill children Ann Med 37 286 294 16019728 10.1080/07853890510007250 (Pubitemid 40911066)